
S2 Ep59: Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC
Update: 2025-07-30
Share
Description
Kevin Chen, PharmD, MS, BCOP, CPP, and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the new approved drug taletrectinib.
Comments
In Channel